Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma

  1. Melchor, J.
  2. Garcia-Lacarte, M.
  3. Grijalba, S.C.
  4. Arnaiz-Leché, A.
  5. Pascual, M.
  6. Panizo, C.
  7. Blanco, O.
  8. Segura, V.
  9. Novo, F.J.
  10. Valero, J.G.
  11. Pérez-Galán, P.
  12. Martinez-Climent, J.A.
  13. Roa, S.
Journal:
Journal for immunotherapy of cancer

ISSN: 2051-1426

Year of publication: 2023

Volume: 11

Issue: 2

Type: Article

DOI: 10.1136/JITC-2022-006113 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus